Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Steven M Monda

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
BJU International|September 12, 2024
Differences in mutations across tumour sizes in clear-cell renal cell carcinomaSteven M Monda, Benjamin W Carney, Allison M May, et al.
JCO Precision Oncology|June 6, 2025
Validation of a 15-Gene Prognostic Signature in Metastatic Clear Cell Renal Cell CarcinomaSteven M Monda, Srinivas Nallandhighal, Ulka Vaishampayan, et al.
BJU International|November 12, 2025
A prospective study of minimal residual disease in urological cancers using circulating tumour DNAArnav Srivastava, Derrian Cooley, Steven M Monda, et al.
European Urology Open Science|April 17, 2026
Germline Variants in Bladder and Upper Tract Urothelial Cancers: Prevalence and Clinical Context in a Large Testing RegistrySteven M Monda, Eugene Oh, Patrick J Lewicki, et al.
Clinical Genitourinary Cancer|June 12, 2026
Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate CancerTodd M Morgan, Lauren H Lenz, Ivan Henriquez, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
BJU International|September 12, 2024
Differences in mutations across tumour sizes in clear-cell renal cell carcinomaSteven M Monda, Benjamin W Carney, Allison M May, et al.
JCO Precision Oncology|June 6, 2025
Validation of a 15-Gene Prognostic Signature in Metastatic Clear Cell Renal Cell CarcinomaSteven M Monda, Srinivas Nallandhighal, Ulka Vaishampayan, et al.
BJU International|November 12, 2025
A prospective study of minimal residual disease in urological cancers using circulating tumour DNAArnav Srivastava, Derrian Cooley, Steven M Monda, et al.
European Urology Open Science|April 17, 2026
Germline Variants in Bladder and Upper Tract Urothelial Cancers: Prevalence and Clinical Context in a Large Testing RegistrySteven M Monda, Eugene Oh, Patrick J Lewicki, et al.
Clinical Genitourinary Cancer|June 12, 2026
Robust Meta-Analysis of a Clinical Cell-Cycle Risk (CCR) Score Demonstrates Broadly Applicable Metastasis and Disease-Specific Mortality Risk Stratification in Men With Localized Prostate CancerTodd M Morgan, Lauren H Lenz, Ivan Henriquez, et al.
Pageof 2